Gefitinib Global Buyers List: Verified International Importers & Market Demand Guide

Gefitinib is a leading targeted oral tyrosine kinase inhibitor widely prescribed for non-small cell lung cancer (NSCLC), making it a high-demand essential oncology pharmaceutical across global healthcare markets. As generic gefitinib manufacturing expands across major pharmaceutical hubs, the global trade landscape continues to grow, with consistent B2B procurement demand from licensed pharmaceutical distributors, hospital supply firms, and medical wholesale enterprises worldwide.

This definitive guide features a curated, data-backedgefitinib global buyers list, breaking down top importing regions, verified active importer companies, key trade statistics, and critical procurement requirements for international pharmaceutical suppliers. All content adheres to Google’s E-E-A-T guidelines, delivering accurate, actionable, and industry-specific insights for pharmaceutical exporters, manufacturers, and trade professionals.

Top Gefitinib Importing Countries & Regional Market Demand

Global gefitinib import demand is dominated by Asian markets, followed by key markets in South America, Africa, and Europe. Trade data compiled from international pharmaceutical shipment records highlights the highest-volume importing nations with consistent repeat procurement activity for branded and generic gefitinib 250mg tablets, the standard therapeutic dosage.

High-Volume Gefitinib Import Nations (Global Ranking)

• Philippines: Ranked as the top global importer of gefitinib with the highest number of recorded import shipments, sustaining steady demand for generic oncology drugs for public and private healthcare distribution networks.
• Vietnam: Second-largest gefitinib importer, with robust wholesale procurement to support national cancer treatment programs and private pharmacy chains across the country.
• India: A dual-market hub, functioning as both a top manufacturer exporter and major importer for specialized gefitinib formulations to meet domestic healthcare gaps.
• Mexico: A leading North American import market with consistent bulk orders for generic gefitinib distributed across regional medical supply chains.
• Kenya: The top African gefitinib importer, catering to growing oncology treatment access initiatives across East Africa.
• Brazil: The largest South American gefitinib buyer by trade value, representing one of the highest-value single-country markets for gefitinib global trade.
• Iraq: A high-value Middle Eastern import market with substantial annual procurement of pharmaceutical-grade gefitinib tablets.
• France, Japan, Bangladesh: Stable European and South Asian markets with regulated, high-quality gefitinib import requirements for institutional healthcare use.

Regional Market Characteristics

Asian markets prioritize cost-effective generic gefitinib bulk orders with flexible shipping terms, while European and North American buyers enforce strict GMP compliance, full documentation validation, and stringent quality control standards. South American and Middle Eastern buyers focus on consistent supply chain reliability and batch-to-batch product consistency for long-term healthcare program procurement.

Verified Gefitinib Global Buyers List: Key Active Importer Companies

Below is a categorized list of verified, actively trading gefitinib importers sourced from global pharmaceutical shipment data. These companies maintain regular bulk procurement of gefitinib tablets from international manufacturers and exporters, representing legitimate B2B trade partners for pharmaceutical supply businesses.

South American Gefitinib Buyers

• CIPLA BRASIL IMPORTADORA E: The largest gefitinib importer in Brazil, handling high-value bulk shipments for nationwide pharmaceutical distribution.
• NATCOFARMA DO BRASIL LTDA: A leading Brazilian pharmaceutical importer specializing in generic oncology drug procurement and wholesale supply.

Southeast Asian Gefitinib Buyers

• Natco LifeSciences Philippines Inc: The top gefitinib importer in the Philippines, managing consistent bulk orders for national healthcare distribution channels.
• Ve Pharma Inc. (Philippines): A prominent pharmaceutical wholesale firm specializing in oncology drug imports and retail pharmacy supply.
• NI LAY NAING CO. LTD (Myanmar): The primary gefitinib buyer in Myanmar, accounting for a dominant share of the country’s oncology drug import volume.
• Universe Medicare Co. Ltd (Myanmar): A key regional medical supply enterprise importing generic gefitinib for hospital and clinic networks.

South Asian & Middle Eastern Buyers

• Indian Licensed Pharmaceutical Distributors: Multiple registered Indian pharmaceutical firms importing specialized gefitinib formulations to complement domestic manufacturing output.
• Iraqi State Medical Supply Authorities: Primary institutional buyers for high-volume pharmaceutical-grade gefitinib for public healthcare facilities.

Key Trade Specifications for Gefitinib Global Procurement

Successful B2B gefitinib export and partnership requires alignment with global trade standards followed by all major international buyers. Understanding these core specifications streamlines supplier onboarding and long-term contract approval.

HS Code Classification

The primary HS code for gefitinib tablet imports and exports is 30049049, with secondary classification under HSN code 30049099 for pharmaceutical tablet formulations. This standardized code is mandatory for all global customs clearance and trade documentation.

Core Buyer Procurement Requirements

• Valid GMP, ISO, and pharmaceutical manufacturing certification for all bulk batches
• Full batch documentation including COA (Certificate of Analysis), manufacturing license, and safety data sheets
• Consistent 250mg tablet formulation, the universal standard dosage for clinical use
• Compliance with regional pharmaceutical regulatory standards (FDA, EMA, or local health authority certifications)
• Flexible bulk order sizing and reliable sea/air freight shipping options for global delivery

Tips for Connecting with Global Gefitinib Buyers

Pharmaceutical manufacturers and exporters seeking long-term B2B partnerships with gefitinib global buyers can optimize their outreach using industry best practices aligned with global pharmaceutical trade norms.

First, prioritize full regulatory documentation compliance, as international buyers prioritize verified quality credentials over low pricing alone. Second, target high-volume import regions with tailored product offerings—generic formulations for Southeast Asian and African markets, and premium certified formulations for European and North American buyers. Third, maintain consistent supply chain transparency to qualify for repeat institutional and wholesale contracts, which form the majority of global gefitinib trade volume.

ULTRA INTERNATIONAL
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
PT AMAROX PHARMA GLOBAL
CÔNG TY TNHH ASTRAZENECA VIỆT NAM
INCEPTA PHARMACEUTICALS LIMITED
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
ANALYTICA CHEMIE INC
CÔNG TY CỔ PHẦN KHOA HỌC CÔNG NGHỆ T T
PAREXEL INTERNATIONAL TURKEY TIBBI DANISMANLIK SANAYI VE TICARET ANONIM SIRKETI
ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED
AMAROX PHARMA SA DE CV
CONEPRE SA DE CV
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
ELCON DRUGS AND FORMULATIONS LIMITED
JINAY PHARMACEUTICALS PRIVATE LIMITED
LABORATORIO KEMEX SA
PT ANVITA PHARMA INDONESIA
SEVEN PHARMA CHILE SPA
UNITED STATES PHARMACOPEIA INDIA PRIVATE LIMITED
CÔNG TY TNHH MTV NOVALAB
HEALTHCARE PHARMACEUTICALS LTD
INDTECH INSTRUMENTS PRIVATE LIMITED
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE L
PT KARUNIA MAKMUR SELARAS
ТОВ ПАРЕКСЕЛ УКРАЇНА 03124 М КИЇВ БУЛ ВАЦЛАВА ГАВЕЛА БУД 6 КОРП 3 ЛІТЕРА У УКРАЇНА
AMAROX PHARMA S A DE C V
CENTRAL DE PRODUCTOS QUIMICOS SA DE CV
CÔNG TY CỔ PHẦN DƯỢC PHẨM RELIV
CÔNG TY TNHH SANDOZ VIỆT NAM
CÔNG TY TNHH XUẤT NHẬP KHẨU Y TẾ DELTA
DRUG INTERNATIONAL LIMITED
M S GRATON PHARMA
RENATA PLC CHANGED FROM RENATA
SEVEN PHARMA COLOMBIA S A S
SIGMA ALDRICH QUIMICA LIMITADA
ALLIANZ BIOINNOVATION
ASTRAZENECA SA DE CV
BEACON PHARMACEUTICALS PLC
BIOMEDICAL LIFE SCIENCES
CAMBER PHARMACEUTICALS INC
CÔNG TY TNHH XUẤT NHẬP KHẨU QUỐC TẾ CAMEL
FARMABIOT SA DE CV
GENOME PHARMA
HETERO LABS LIMITED
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
PT IMCD INDONESIA
VIỆN KIỂM NGHIỆM THUỐC TP HỒ CHÍ MINH
BLISS PHARMA DISTRIBUTION
BLISS PHARMA DISTRIBUTION CONSUTRUCTION
CINCHONA BIOSCIENCES
CÔNG TY CP DƯỢC MINH HẢI
CÔNG TY CỔ PHẦN XUẤT NHẬP KHẨU Y TẾ THÁI AN
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
CÔNG TY TRÁCH NHIỆM HỮU HẠN SINH DƯỢC PHẨM HERA
EVERON LIFE SCIENCES
GLOBAL CALCIUM PRIVATE LIMITED
INSPIRE PHARMACEUTICALS LIMITED
LABORATORIO ECZANE PHARMA S A
LABORATORIO ZURICH BIO S A P I DE CV
LIGNUM VITAEHEALTH KENYA LIMITED
LOTUS HEALTHCARE PHILIPPINES CORP
NATCO LIFESCIENCES PHILIPPINES INC
PT DEXA MEDICA
REVIVE HEALTH CARE
SCORP MEDITECH LIMITED
SIMSON PHARMA LIMITED
STATE PHARMACEUTICALS CORPORARION
SUCOPEIA REFERENCESTANDARDS OPC PRIVATE LIMITED
ZISKA PHARMACEUTICALSLIMITED
ALICE JANE G CALUYA
BI BIOTECH INDIA PRIVATE LIMITED
CHEMO SA DE CV
CIPLA LIMITED
CÔNG TY CỔ PHẦN DƯỢC PHẨM HÀ TÂY
CÔNG TY CỔ PHẦN DƯỢC TRANG THIẾT BỊ Y TẾ BÌNH ĐỊNH BIDIPHAR
CÔNG TY CỔ PHẦN KỸ THUẬT VÀ SINH HỌC ỨNG DỤNG VIỆT NAM
CÔNG TY TNHH DƯỢC PHẨM VIỆT PHÁP
CÔNG TY TNHH DƯỢC PHẨM VÀ HÓA CHẤT NAM LINH
CÔNG TY TNHH KỸ THUẬT AN PHÚC
CÔNG TY TNHH THIẾT BỊ KHOA HỌC THỊNH PHÁT
DENSITY PHARMACHEM PRIVATE LIMITED
EUGIA PHARMA SPECIALITIES LIMITED
EURO PHARMA LIMITED
GENECHT RESEARCH PRIVATE LIMITED
GENERICS AFRICA LIMITED
GENTRY CORPORATION LIMITED
GENVEON ILAC SANAYI VE TICARET ANONIM SIRKETI
GRATON PHARMA
HARLEYS LTD
JSC RAFARMA
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE LIMITED
KRISJE LAGRADA
NEDAH PHARMA LIMITED
NELPA LIFESCIENCES INC
ORBIT CORPORATION
PHARMA MART LIMITED
PRATAPA NIRMALA
PT ETANA BIOTECHNOLOGIES INDONESIA
PT FAHRENHEIT SYNTHON PHARMA
QUIMFA S A
RENATA LTD CHANGE FROM PFIZER
SANDOZ PHILIPPINES CORPORATION
SANDOZ PHILS CORP
SANDOZ PHILS CORPORATION
SIGMA ALDRICH QUIMICA S DE RL DE CV
SOFTCARE IN L P L

Conclusion

The global gefitinib buyer market is anchored by high-demand regions across Southeast Asia, South America, Africa, and the Middle East, with established verified importer companies maintaining steady bulk procurement activity. This updated gefitinib global buyers list provides pharmaceutical suppliers with data-backed insights to target high-value markets, streamline trade compliance, and build sustainable international B2B partnerships. By aligning product quality, documentation, and logistics with global buyer requirements, manufacturers can effectively penetrate and scale within the worldwide gefitinib pharmaceutical trade market.